STEPHANI CARVER: Open Payments
NPI 1083207211 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 24 payments from 7 companies in 2025. Trend: 2023 $409 · 2024 $1,029 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $161 |
| Aimmune Therapeutics, Inc. | 3 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $136 |
| Intercept Pharmaceuticals, Inc. | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 4 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
Products named: ZENPEP, ENTYVIO, LINZESS, OCALIVA, RINVOQ, CREON, TREMFYA, VOWST.
Industry payments across FL — which companies pay providers there.
